Cargando…

The peripheral blood neutrophil-to-lymphocyte ratio is a prognostic predictor for survival of EGFR-mutant nonsmall cell lung cancer patients treated with EGFR-TKIs

Epidermal growth factor receptor-tyrosine kinase inhibitors (EGFR-TKIs) are the standard first-line treatment for EGFR-mutant nonsmall cell lung cancer (NSCLC) patients. However, studies have reported that not all NSCLC patients harboring kinase domain mutations in epidermal growth factor receptor (...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Yuan, Feng, Yang-Chun, Zhu, Hong-Ge, Xiong, Ting-Chuan, Hou, Yan-Shen, Song, Jia, Jiang, Wei, Zhu, Chang-Jun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer Health 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6078676/
https://www.ncbi.nlm.nih.gov/pubmed/30045314
http://dx.doi.org/10.1097/MD.0000000000011648